Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natural versus synthetic estrogen oral contraception metabolic effects study
2014-001243-20Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of estradiol, ethinyl estradiol and hydroxyprogesterone caproate in contraception (3 arms), sponsored by Helsinki University Hospital. Primary endpoints: Insulin sensitivity and Markers of chronic inflammation. Started May 2014; status: completed.
02
Drugs
estradiolethinyl estradiolhydroxyprogesterone caproate
03
Conditions
contraception
Beyond the preview
Go deeper on 2014-001243-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001243-20.